Exendin-9,39 and Satiety After Bariatric Surgery
Condition(s):ObesityLast Updated:May 1, 2020Completed
Hide Studies Not Open or Pending
Condition(s):ObesityLast Updated:May 1, 2020Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:March 2, 2018Completed
Condition(s):Type 2 DiabetesLast Updated:October 9, 2014Completed
Condition(s):Type 2 DiabetesLast Updated:January 30, 2017Completed
Condition(s):Type 2 DiabetesLast Updated:June 28, 2010Unknown status
Condition(s):Type 2 DiabetesLast Updated:October 3, 2019Completed
Condition(s):Metabolic Disturbance; Schizophrenia; Type 2 Diabetes; Clozapine; GLP-1; OlanzapineLast Updated:October 10, 2023Recruiting
Condition(s):Heart FailureLast Updated:February 29, 2016Unknown status
Condition(s):Non-Alcoholic Fatty Liver Disease; Insulin Resistance; Glucose Tolerance Impaired; Obesity, AbdominalLast Updated:February 3, 2021Completed
Condition(s):Hyperglucagonemia; Hyperglycemia; Diabetes MellitusLast Updated:June 26, 2008Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.